Audrey Darmon

468 total citations
17 papers, 368 citations indexed

About

Audrey Darmon is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Audrey Darmon has authored 17 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomedical Engineering, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Audrey Darmon's work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Audrey Darmon is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Audrey Darmon collaborates with scholars based in United States, France and Italy. Audrey Darmon's co-authors include Julie Marill, Sébastien Paris, Ping Zhang, Matthieu Germain, Catherine de Coupade, Antonio Fittipaldi, Jonathan Kearsey, Denis Ravel, Françoise Cailler and Ennio Tasciotti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and Cancer Research.

In The Last Decade

Audrey Darmon

17 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Audrey Darmon United States	7	195	139	91	71	52	17	368
Stéphane Desgranges France	13	226 1.2×	165 1.2×	49 0.5×	92 1.3×	24 0.5×	23	481
Guangyu Rong China	9	227 1.2×	111 0.8×	31 0.3×	100 1.4×	38 0.7×	16	385
Lynn De Backer Belgium	9	308 1.6×	119 0.9×	169 1.9×	112 1.6×	38 0.7×	11	489
Rujuan Wang China	6	159 0.8×	123 0.9×	47 0.5×	110 1.5×	15 0.3×	6	315
Zhao-Hui Jin France	10	171 0.9×	117 0.8×	55 0.6×	46 0.6×	57 1.1×	25	399
Yuran Xie United States	11	314 1.6×	52 0.4×	54 0.6×	63 0.9×	42 0.8×	16	406
Yeshan Qin China	6	160 0.8×	304 2.2×	27 0.3×	46 0.6×	54 1.0×	7	532
Saisai Xiong China	9	85 0.4×	302 2.2×	48 0.5×	82 1.2×	40 0.8×	12	410
Emma McErlean United Kingdom	9	229 1.2×	107 0.8×	21 0.2×	139 2.0×	69 1.3×	14	429
Katarzyna Zabielska-Koczywąs Poland	12	109 0.6×	62 0.4×	129 1.4×	66 0.9×	27 0.5×	21	352

Countries citing papers authored by Audrey Darmon

Since Specialization

Citations

This map shows the geographic impact of Audrey Darmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Darmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Darmon more than expected).

Fields of papers citing papers by Audrey Darmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Darmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Darmon. The network helps show where Audrey Darmon may publish in the future.

Co-authorship network of co-authors of Audrey Darmon

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Darmon. A scholar is included among the top collaborators of Audrey Darmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Darmon. Audrey Darmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Darmon, Audrey, et al.. (2022). Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire. Cancer Cell International. 22(1). 208–208. 12 indexed citations

Zhang, Ping, et al.. (2021). NBTXR3 Radiotherapy-Activated Functionalized Hafnium Oxide Nanoparticles Show Efficient Antitumor Effects Across a Large Panel of Human Cancer Models. International Journal of Nanomedicine. Volume 16. 2761–2773. 41 indexed citations

Saunders, Nell, Owen S. Fenton, Laurence Poul, et al.. (2020). A Nanoprimer To Improve the Systemic Delivery of siRNA and mRNA. Nano Letters. 20(6). 4264–4269. 72 indexed citations

Zhang, Ping, et al.. (2020). <p>Radiotherapy-Activated Hafnium Oxide Nanoparticles Produce Abscopal Effect in a Mouse Colorectal Cancer Model</p>. International Journal of Nanomedicine. Volume 15. 3843–3850. 53 indexed citations

Darmon, Audrey, Ping Zhang, & Sébastien Paris. (2020). 582 Modulation of TCR repertoire by radiotherapy-activated NBTXR3 nanoparticles. SHILAP Revista de lepidopterología. A349.1–A349. 1 indexed citations

Rodríguez-Ruiz, María E., et al.. (2019). Abstract 536: NBTXR3 potentiate cancer-cell intrinsic interferon beta response to radiotherapy. Cancer Research. 79(13_Supplement). 536–536. 6 indexed citations

Germain, Matthieu, et al.. (2019). Abstract 3613: Mononuclear phagocytic system occupancy to increase nanomedicines based treatment efficacy. Cancer Research. 79(13_Supplement). 3613–3613. 2 indexed citations

Hu, Yun, Ping Zhang, Audrey Darmon, et al.. (2019). Abstract 3225: Enhancement of anti-PD1 and anti-CTLA4 efficacy by NBTXR3 nanoparticles exposed to radiotherapy. Immunology. 3225–3225. 1 indexed citations

Zhang, Ping, et al.. (2019). Abstract 3225: Enhancement of anti-PD1 and anti-CTLA4 efficacy by NBTXR3 nanoparticles exposed to radiotherapy. Cancer Research. 79(13_Supplement). 3225–3225. 1 indexed citations

10.

Rodríguez-Ruiz, María E., et al.. (2019). Abstract 536: NBTXR3 potentiate cancer-cell intrinsic interferon beta response to radiotherapy. Immunology. 536–536. 1 indexed citations

11.

Marill, Julie, et al.. (2018). Abstract 4571: Activation of the cGAS-STING pathway by NBTXR3 nanoparticles exposed to radiotherapy. Cancer Research. 78(13_Supplement). 4571–4571. 1 indexed citations

12.

Poul, Laurence, Audrey Darmon, Matthieu Germain, et al.. (2017). A new opportunity for nanomedicines: Micellar cytochrome P450 inhibitors to improve drug efficacy in a cancer therapy model. Nanomedicine Nanotechnology Biology and Medicine. 13(5). 1715–1723. 2 indexed citations

13.

Poul, Laurence, Matthieu Germain, Audrey Darmon, et al.. (2017). Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel. International Journal of Nanomedicine. Volume 12. 5537–5556. 15 indexed citations

14.

Darmon, Audrey, Sonia Vivet, Ping Zhang, et al.. (2011). Abstract 2665: NBTXR3 hafnium oxide nanoparticle activated by ionizing radiation demonstrates marked radio-enhancement and antitumor effect via high energy deposit in human soft tissue sarcoma. Cancer Research. 71(8_Supplement). 2665–2665. 3 indexed citations

15.

Germain, Matthieu, Virginie Simon, Audrey Darmon, et al.. (2010). One pot synthesis of new hybrid versatile nanocarrier exhibiting efficient stability in biological environment for use in photodynamic therapy. Journal of Photochemistry and Photobiology B Biology. 100(1). 1–9. 5 indexed citations

16.

Simon, Virginie, Corinne Devaux, Audrey Darmon, et al.. (2009). Pp IX Silica Nanoparticles Demonstrate Differential Interactions with In Vitro Tumor Cell Lines and In Vivo Mouse Models of Human Cancers. Photochemistry and Photobiology. 86(1). 213–222. 36 indexed citations

17.

Coupade, Catherine de, Antonio Fittipaldi, Ennio Tasciotti, et al.. (2005). Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. Biochemical Journal. 390(2). 407–418. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact